Mr. Conerly joins Rib-X from Pharmion Corporation in Boulder, Colorado where, as Chief Financial Officer and Vice President of Finance, he led the specialty pharmaceutical company through a $65 million private equity financing in November, 2001. Prior to Pharmion, Mr. Conerly spent six years at AstraZeneca PLC, both in the US and Europe, in numerous financial positions. As Director of Business Performance for the newly merged AstraZeneca he led senior management in the development and monitoring of performance objectives. Mr. Conerly began his professional career at Price Waterhouse where he advanced to Senior Manager and worked in Audit Advisory Services, the Entrepreneurial Services Center and the Mergers and Acquisitions Group.